Ross Nevin England, MD, PhD
Travel Medicine, Infectious Diseases
Headshot of Ross Nevin England, MD, PhD
Schedule onlineCall 800-789-7366

Ross Nevin England, MD, PhD

Travel Medicine, Infectious Diseases
Accepting new patients
Sees patients age newborn and up
MacGregor Infection Medicine and Travel Program
View 1 additional location
Schedule onlineCall 800-789-7366
Headshot of Ross Nevin England, MD, PhD
Penn Medicine Provider

About me

  • Assistant Professor of Pediatrics (Infectious Diseases)
  • Assistant Professor of Medicine (Infectious Diseases)

My education and training

  • Temple University School of MedicineMedical School
  • Massachusetts General Hospital/Brigham and Women’s HospitalResidency
  • University of Pennsylvania Health SystemFellowship
  • Children's Hospital of PhiladelphiaFellowship

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

PRIMARY LOCATION
800-789-7366
Learn about location
610-902-5618
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. England is a Penn Medicine provider.

Qualifications and experience

Treatments and conditions

Research

Publications

England RN, Gannon SLM, Ort JT A Measles mRNA-LNP Vaccine Elicits High-Titer Antibody Responses Exceeding Live-Attenuated Measles Virus in a Mouse Model. , Poster presentation at IDWeek, Washington D.C.: 2026

Gannon SLM (presenting author), Ort JT, England RN. Developing a measles maternal antibody mouse model using mRNA-lipid nanoparticles. , Poster presentation at the Pediatric Academic Societies (PAS) Meeting, Boston, MA.: 2026

Alemayehu T, England RN, Oguttu B, Jarovsky, D Should birth-dose vaccines for preterm newborns still be debated. , Int J Infect Dis, 154(1): 2025,107866

England RN, Drapeau EM, Alameh M-G, Hosseinzadeh R,Weissman D, Hensley SE Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model. , npj Vaccines, 9(1): 2024,110

England RN, Drapeau EM, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNALNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model , Hospital of the University of Pennsylvania, Department of Medicine Research Day, Philadelphia, PA, Podium: 2023

England RN, Drapeau EM, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNALNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model , Centers of Excellence for Influenza Research and Response Annual CEIRR Network Meeting, Baltimore, MD, Podium: 2023

England RN, Drapeau EM, Hosseinzadeh R, Weissman D, Hensley SE Evaluation of mRNALNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model , IDWeek, Boston, MA, Poster: 2023

Gabryszewski SJ, England RN, Sun D, Gentile TL, Hochgertel W, Jyonouchi S, Silverman M, Zaoutis T, Sullivan KE, Henrickson SE Self-Limited COVID-19 in a Patient with Artemis SCID. , J Clin Immunol, 41(8): 2021,1745-1747

Shields BE, Perelygina L, Samimi S, Haun P, Leung T, Abernathy E, Chen MH, Hao L, Icenogle J, Drolet B, Wilson B, Bryer JS, England R, Blumberg E, Wanat K, Sullivan K, Rosenbach M Granulomatous Dermatitis Associated with Rubella Virus Infection in an Adult with Immunode ciency. , JAMA Dermatol, 157(7): 2021,842-847

England R, Pak J, Liu M, Rao S, Azono O, Levy O, van Haren SD Human Blood Plasma Shapes Distinct Neonatal TLR-Mediated Dendritic Cell Activation via Expression of the Mi-croRNA Let-7g. , Immunohorizons, 5(4): 2021,246-256